This profile was created from public SEC EDGAR information. Is this you? Claim it, correct it or remove it.

Claim it Correct or add Remove it Report a problem

David Kirn

Officer and Director, 4D Molecular Therapeutics, Inc., as of Oct 2026

From SEC EDGAR, not claimed yetUpdated Oct 17, 2026

David Kirn is Officer and Director at 4D Molecular Therapeutics, Inc.

Officer and director of 4D Molecular Therapeutics, Inc.

Works at

44D Molecular Therapeutics, Inc.Officer and Directorfrom SEC EDGAR

as of Oct 2026, from an SEC filing